Blog _Blog What are the next steps for therapeutic cannabis in France? Read more » April 24, 2024 _Blog Poisonous Substances: What Use within the Pharmaceutical Industry? Read more » March 19, 2024 _Blog Therapeutic patient education versus learning programs: what is role for the pharmaceutical industry? Read more » March 7, 2024 _Blog What is the Requirement for Transparency of Conflicts of Interest with Healthcare Professionals in France? Read more » December 20, 2023 _Blog What are the mechanisms for early and compassionate access in France? Read more » November 28, 2023 _Blog What about the classification of Marketing Authorization variations? Read more » November 27, 2023 _Blog What Are the French Rules for Influencers on Social Networks? Read more » October 20, 2023 _Blog The Relationship Between the Healthcare Industry and Healthcare Professionals: Challenges and Developments Read more » June 22, 2023 _Blog The Responsible Pharmacist status, a French specificity Read more » April 20, 2023 _Blog The serialisation system Read more » February 20, 2023 _Blog The APQR review “à la française” Read more » February 1, 2023 _Blog The consulting profession at ATESSIA Read more » January 24, 2023 Page1 Page2 Page3 Page4
_Blog Therapeutic patient education versus learning programs: what is role for the pharmaceutical industry? Read more » March 7, 2024
_Blog What is the Requirement for Transparency of Conflicts of Interest with Healthcare Professionals in France? Read more » December 20, 2023
_Blog What are the mechanisms for early and compassionate access in France? Read more » November 28, 2023
_Blog What about the classification of Marketing Authorization variations? Read more » November 27, 2023
_Blog The Relationship Between the Healthcare Industry and Healthcare Professionals: Challenges and Developments Read more » June 22, 2023
